Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference PR Newswire QUÉBEC CITY, March 13, 2013 QUÉBEC CITY, March 13, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:AEZ) (the"Company") today announced that its President and CEO, Juergen Engel, PhD, will be presenting a corporate overview at the Roth 25^th Annual OC Growth Stock Conference on Tuesday, March 19, 2013, at 9:30 am (Pacific), in Track 6: Salon 5-Pink of the Ritz Carlton hotel in Dana Point, California. A live webcast of this slide presentation will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days. About Aeterna Zentaris Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com. SOURCE AETERNA ZENTARIS INC. Contact: Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. 265 email@example.com Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. 406 firstname.lastname@example.org
Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference
Press spacebar to pause and continue. Press esc to stop.